Plexxikon Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
65
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$935M
Plexxikon General Information
Description
Manufacturer of small molecule pharmaceutical products designed to treat human disease. The company's products are used for the treatment of melanoma and colorectal cancer; and for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease. enabling doctors to provide treatment for metabolic diseases, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis.
Contact Information
Website
www.plexxikon.comCorporate Office
- 329 Oyster Point
- South San Francisco, CA 94080
- United States
Corporate Office
- 329 Oyster Point
- South San Francisco, CA 94080
- United States
Plexxikon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 04-Apr-2011 | $935M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series B2) | 03-Nov-2009 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B1) | 08-Mar-2005 | Completed | Startup | |||
| 2. Early Stage VC | 15-Jan-2003 | $31.1M | $31.1M | Completed | Startup | |
| 1. Early Stage VC | Completed | Startup |
Plexxikon Patents
Plexxikon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230081426-A1 | Compounds and methods for kras modulation and indications therefor | Inactive | 18-Sep-2020 | ||
| WO-2022061251-A1 | Compounds and methods for kras modulation and indications therefor | Inactive | 18-Sep-2020 | ||
| JP-2023542473-A | Combination drug anticancer treatment | Pending | 21-Aug-2020 | ||
| CA-3192047-A1 | Combinational drug anticancer therapies | Pending | 21-Aug-2020 | ||
| WO-2022040512-A1 | Combinational drug anticancer therapies | Inactive | 21-Aug-2020 | A61K31/58 |
Plexxikon Signals
Plexxikon Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advanced Technology Ventures | Venture Capital | Minority | ||
| Alta Partners | Venture Capital | Minority | ||
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| Bock Family Ventures | Venture Capital | Minority | ||
| CW Group | Venture Capital | Minority |
Plexxikon FAQs
-
When was Plexxikon founded?
Plexxikon was founded in 2000.
-
Where is Plexxikon headquartered?
Plexxikon is headquartered in South San Francisco, CA.
-
What is the size of Plexxikon?
Plexxikon has 65 total employees.
-
What industry is Plexxikon in?
Plexxikon’s primary industry is Pharmaceuticals.
-
Is Plexxikon a private or public company?
Plexxikon is a Private company.
-
What is the current valuation of Plexxikon?
The current valuation of Plexxikon is .
-
What is Plexxikon’s current revenue?
The current revenue for Plexxikon is .
-
How much funding has Plexxikon raised over time?
Plexxikon has raised $61.1M.
-
Who are Plexxikon’s investors?
Advanced Technology Ventures, Alta Partners, Astellas Venture Management, Bock Family Ventures, and CW Group are 5 of 9 investors who have invested in Plexxikon.
-
When was Plexxikon acquired?
Plexxikon was acquired on 04-Apr-2011.
-
Who acquired Plexxikon?
Plexxikon was acquired by Daiichi Sankyo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process